Related references
Note: Only part of the references are listed.Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis
Ibai Los-Arcos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Global epidemiology of urinary tract infections
Zafer Tandogdu et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2016)
Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs
M. Lindsay Grayson et al.
CLINICAL INFECTIOUS DISEASES (2015)
Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin
Yang Hyun Cho et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2015)
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Ana L. Flores-Mireles et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Fosfomycin versu meropenem in bacteraemic urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
Clara Rosso-Fernandez et al.
BMJ OPEN (2015)
Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?
Asfia Sultan et al.
UROLOGY ANNALS (2015)
Extended-spectrum beta-lactamases in urinary tract infections caused by Enterobacteria: Understanding and guidelines for action
A. Garcia-Tello et al.
ACTAS UROLOGICAS ESPANOLAS (2014)
Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study
Antonio Sorlozano et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2014)
Urinary Tract Infection Syndromes Occurrence, Recurrence, Bacteriology, Risk Factors, and Disease Burden
Betsy Foxman
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2014)
Diagnosis and Management of Urinary Tract Infections in the Outpatient Setting A Review
Larissa Grigoryan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections
Filip Jansaker et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Fosfomycin for the Treatment of Resistant Gram-Negative Bacterial Infections Insights from the Society of Infectious Diseases Pharmacists
Julia L. Reffert et al.
PHARMACOTHERAPY (2014)
A new strategy to fight antimicrobial resistance: the revival of old antibiotics
Nadim Cassir et al.
FRONTIERS IN MICROBIOLOGY (2014)
Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study
Lu-Dong Qiao et al.
BMJ OPEN (2013)
Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms
Elizabeth A. Neuner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
Drosos E. Karageorgopoulos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy
S. Meier et al.
INFECTION (2011)
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
David M. Livermore et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum β-lactamase (ESBL)-producing Escherichia coli
Jesus Oteo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli-Related Complicated Lower Urinary Tract Infection
S. Senol et al.
JOURNAL OF CHEMOTHERAPY (2010)
Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Jesus Rodriguez-Bano et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Fosfomycin: Use beyond urinary tract and gastrointestinal infections
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections
Husnu Pullukcu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Share Paper
